ISPOR - EPH125 Potential Health Effects of a Blood-Based Genomic Test Used to Prescreen Individuals Eligible for Lung Cancer Screening in the U.S.

EPH125 Potential Health Effects of a Blood-Based Genomic Test Used to Prescreen Individuals Eligible for Lung Cancer Screening in the U.S.

Abstract

Authors

P Bach J Ortendahl N Trivedi C Cisar

Full Text Cite This Article

Back to Volume 25, Supplemental Issue 12S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now